In line with our results, studies investigating MR imaging characteristics of primary breast tumors reported higher heterogeneity for triple-negative and HER2+ lesions compared to hormone-receptor-positive tumors [49,50]. This evidence concerns the gene NR4A1 and breast neoplasm.